Poster Session

[P33] Poster Session 33　Breast Cancer（Basic science, Biomarker）

+Add all to schedule

[P33-1] L-lysine increase the anticancer effect of Doxorubicin in breast cancer: Relevance of the oxidative stress and autophagy

^○Kamran Mansouri (Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran)

[P33-2] PARP inhibitor has synergic effect with mTOR inhibitor or E2 for treatment-resistant model cells of ER（+）breast cancer

^○Minori Tsukahara (Department of Molecular and Functional Dynamics, Graduate School of Medicine, Tohoku University)

[P33-3] Prognostic impact of co-expression of LLCL2 and SLC7A5 in ERα-positive breast cancer patients

^○Tomoka Hisada¹, Naoto Kondo¹, Yumi Wanifuchi-Endo¹, Tomoko Asano¹, Yasuaki Uemoto¹, Akiko Kato¹, Mitsuo Terada¹, Hiroyuki Kato², Masayuki Komura², Satoshi Morita³, Satoru Takahashi², Tatsuya Toyama¹ (1.Department of Breast Surgery, Nagoya City University Graduate School of Medical Science, 2.Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Science, 3.Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine)